{"protocolSection":{"identificationModule":{"nctId":"NCT02783573","orgStudyIdInfo":{"id":"16024"},"secondaryIdInfos":[{"id":"I8D-MC-AZET","type":"OTHER","domain":"Eli Lilly and Company"},{"id":"2015-005625-39","type":"EUDRACT_NUMBER"}],"organization":{"fullName":"AstraZeneca","class":"INDUSTRY"},"briefTitle":"A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled and Delayed-Start Study of LY3314814 in Mild Alzheimer's Disease Dementia","acronym":"DAYBREAK-ALZ"},"statusModule":{"statusVerifiedDate":"2019-10","overallStatus":"TERMINATED","whyStopped":"An independent assessment concluded the trial was not likely to meet the primary endpoint upon completion and therefore, trial stopped for futility.","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2016-07-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2018-09-28","type":"ACTUAL"},"completionDateStruct":{"date":"2018-09-28","type":"ACTUAL"},"studyFirstSubmitDate":"2016-05-24","studyFirstSubmitQcDate":"2016-05-24","studyFirstPostDateStruct":{"date":"2016-05-26","type":"ESTIMATED"},"resultsFirstSubmitDate":"2019-06-11","resultsFirstSubmitQcDate":"2019-07-15","resultsFirstPostDateStruct":{"date":"2019-08-06","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-11-19","lastUpdatePostDateStruct":{"date":"2019-12-03","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"AstraZeneca","class":"INDUSTRY"},"collaborators":[{"name":"Eli Lilly and Company","class":"INDUSTRY"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The main purpose of this study is to evaluate the efficacy of the study drug known as lanabecestat in participants with mild Alzheimer's disease (AD) dementia."},"conditionsModule":{"conditions":["Alzheimer's Disease"],"keywords":["dementia","brain diseases","neurodegenerative diseases","central nervous system diseases","nervous system diseases","mental disorders","delirium, dementia, amnestic, cognitive","tauopathies","memory","amyloid"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"TRIPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR"]}},"enrollmentInfo":{"count":1722,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Lanabecestat 20 milligrams (mg)","type":"EXPERIMENTAL","description":"Participants received Lanabecestat 20 mg film-coated tablets orally once daily until week 156.","interventionNames":["Drug: Lanabecestat"]},{"label":"Lanabecestat 50 mg","type":"EXPERIMENTAL","description":"Participants received Lanabecestat 50 mg film-coated tablets orally once daily until week 156.","interventionNames":["Drug: Lanabecestat"]},{"label":"Placebo/ Lanabecestat 20 mg","type":"EXPERIMENTAL","description":"Placebo given orally once daily for 78 weeks and then 20 mg of lanabecestat given orally once daily until week 156.","interventionNames":["Drug: Lanabecestat","Drug: Placebo"]},{"label":"Placebo/ Lanabecestat 50 mg","type":"EXPERIMENTAL","description":"Placebo given orally once daily for 78 weeks and then 50 mg of lanabecestat given orally once daily until week 156.","interventionNames":["Drug: Lanabecestat","Drug: Placebo"]}],"interventions":[{"type":"DRUG","name":"Lanabecestat","description":"Administered orally","armGroupLabels":["Lanabecestat 20 milligrams (mg)","Lanabecestat 50 mg","Placebo/ Lanabecestat 20 mg","Placebo/ Lanabecestat 50 mg"],"otherNames":["LY3314814","AZD3293"]},{"type":"DRUG","name":"Placebo","description":"Administered orally","armGroupLabels":["Placebo/ Lanabecestat 20 mg","Placebo/ Lanabecestat 50 mg"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Change From Baseline in Alzheimer´s Disease Assessment Scale- Cognitive Subscale (ADAS-Cog13) Score","description":"ADAS-Cog13 (13-item version of ADAS Cog) is a psychometric instrument that evaluates word recall, ability to follow commands, constructional praxis, naming, ideational praxis, orientation, word recognition, memory, comprehension of spoken language, word-finding, and language ability, with a measure of delayed word recall and concentration/ distractibility. The total score of the 13-item scale ranges from 0 to 85, with an increase in score indicating cognitive worsening. Least Squares (LS) mean was determined by mixed-model repeated measures (MMRM) model with factors for treatment, visit, treatment-by-visit interaction, acetylcholinesterase Inhibitor (AChEI) use at baseline, pooled site, and covariates for baseline ADAS-Cog13 total score, age at baseline, and baseline ADAS-Cog13 total score-by-visit interaction.","timeFrame":"Baseline, Week 78"}],"secondaryOutcomes":[{"measure":"Change From Baseline in Alzheimer´s Disease Cooperative Study Activities of Daily Living Inventory Instrumental Items Score (ADCS-iADL)","description":"The ADCS-ADL is a 23-item inventory developed as a rater-administered questionnaire answered by the participant's caregiver. The ADCS-ADL measures both basic and instrumental activities of daily living by participants. The range for the ADCS-iADL is 0-59 with higher scores reflecting better performance. LS Mean was determined by MMRM model with factors for treatment, visit, treatment-by-visit interaction, AChEI use at baseline, pooled site, and covariates for baseline iADL score, age at baseline, and baseline iADL score-by-visit interaction.","timeFrame":"Baseline, Week 78"},{"measure":"Change From Baseline in Functional Activities Questionnaire (FAQ) Score","description":"FAQ is a 10-item, caregiver-based questionnaire and was administered to the study partner who was asked to rate the participant's ability to perform a variety of activities ranging from writing checks, assembling tax records, shopping, playing games, food preparation, traveling, keeping appointments, traveling out of neighborhood, keeping track of current events and understanding media. FAQ total score was calculated by adding the scores from each of the 10 items. Each activity is rated on a scale from 0 to 3 (Never did and would have difficulty now=1; never did \\[the activity\\] but could do now=0; normal=0; has difficulty but does by self=1; requires assistance=2; Dependent =3). FAQ scale is 0 to 30, with higher scores indicating greater impairment. LS Mean determined by MMRM model with factors for treatment, visit, treatment-by-visit interaction, AChEI use at baseline, pooled site, and covariates for baseline FAQ total score, by-visit interaction and age at baseline.","timeFrame":"Baseline, Week 78"},{"measure":"Change From Baseline on the Integrated Alzheimer's Disease Rating Scale (iADRS) Score","description":"The iADRS is a composite that measures both cognition and function. The iADRS comprises scores form the ADAS- Cog and the ADCS-iADL. The iADRS is calculated as a linear combination of the total scores of the ADAS-Cog13 (score range 0 to 85 with higher scores reflecting worse performance) and the ADCS-iADL (score range from 0-59 with higher scores reflecting better performance). The iADRS score ranges from 0 to 144 with higher scores indicating greater impairment. LS Mean was determined by MMRM with factors for treatment, visit, treatment-by-visit interaction, AChEI use at baseline, pooled site, and covariates for baseline iADRS13 total score, age at baseline, and baseline iADRS13 total score-by-visit interaction.","timeFrame":"Baseline, Week 78"},{"measure":"Change From Baseline in the Clinical Dementia Rating - Sum of Boxes (CDR-SB) Score","description":"The CDR-SB is a rater administered scale and impairment is scored in each of categories: memory, orientation, judgment and problem solving, community affairs, home and hobbies and personal care. Impairment is scored on a scale in which no dementia = 0, questionable dementia = 0.5, mild dementia = 1, moderate dementia = 2 and severe dementia = 3. The 6 individual category ratings, or \"box scores\", were added together to give the CDR-Sum of Boxes which ranges from 0-18, with higher scores indicating greater impairment. LS Mean was determined by MMRM methodology with factors for treatment, visit, treatment-by-visit interaction, AChEI use at baseline, pooled site, and covariates for baseline CDR-SB score, age at baseline, and baseline CDR-SB score-by-visit interaction.","timeFrame":"Baseline, Week 78"},{"measure":"Time to Progression as Measured by Loss of Clinical Dementia Rating (CDR) Global Score Stage","description":"The CDR global score is a composite score calculated using the Washington University CDR-assignment algorithm applied to the 6 individual domain box scores (Morris 1993). The memory domain is considered the primary category that drives the CDR global outcome, and all other domains are secondary. The CDR global score ranges from 0 to 3 (0 = no dementia, 0.5 = questionable dementia, 1 = mild dementia, 2 = moderate dementia, 3 = severe dementia).","timeFrame":"From Loss of 1 Global Stage through Week 78"},{"measure":"Change From Baseline in Neuropsychiatric Inventory (NPI) Score","description":"The NPI is a questionnaire administered to caregivers that quantifies behavioral changes. Each of the 12 behavioral domains the caregiver reports as present are scored for Frequency, scale: 1 (Occasionally) to 4 (Very Frequently), and Severity, scale: 1 (Mild) to 3 (Severe). If the domain is reported by the caregiver as 'Not Affected,' that domain is scored as 0. The individual domain scores are calculated by multiplying the frequency times the severity for each domain. NPI Total Score is calculated by adding the individual domain scores together for all 12 domains, with a scores range from 0 to 144, with higher scores indicating a greater severity of neuropsychiatric disturbance. LS Mean was determined by MMRM methodology with factors for treatment, visit, treatment-by-visit interaction, AChEI use at baseline, pooled site, and covariates for baseline NPI score, age at baseline, and baseline NPI score-by-visit interaction.","timeFrame":"Baseline, Week 78"},{"measure":"Change From Baseline on the Mini-Mental State Examination (MMSE)","description":"The MMSE is an instrument used to assess a participant's global cognitive function. The MMSE assesses orientation to time and place, immediate and delayed recall of words, attention and calculation, language (naming, comprehension and repetition), and spatial ability (copying a figure). The range for MMSE total Score is 0 to 30, with a higher score indicating better cognitive performance. LS Mean was determined by MMRM methodology with factors for treatment, visit, treatment-by-visit interaction, AChEI use at baseline, pooled site, and covariates for baseline MMSE total score, age at baseline, and baseline MMSE total score-by-visit interaction.","timeFrame":"Baseline, Week 78"},{"measure":"Percent Change From Baseline in Concentration of Cerebrospinal Fluid (CSF) Biomarker Amyloid Beta (Aβ)1-42","description":"Concentration of the peptide Aβ 1-42 in plasma measured by validated immunoassay. LS Mean was determined by Analysis of covariance (ANCOVA) with last observation carried forward (LOCF), terms for treatment, baseline biomarker and age at baseline.","timeFrame":"Baseline, Week 71"},{"measure":"Percent Change From Baseline in Concentration of CSF Biomarker Aβ1-40","description":"Concentration of the peptide Aβ 1-40 in plasma measured by immunoassay. LS Mean was determined by ANCOVA with LOCF (last observation carried forward), terms for treatment, baseline biomarker and age at baseline.","timeFrame":"Baseline, Week 71"},{"measure":"Change From Baseline in CSF Biomarker Total Tau","description":"Cerebrospinal fluid samples were collected for analysis of concentration total tau. LS Mean was determined by ANCOVA with LOCF and with factors for treatment, baseline biomarker and age at baseline.","timeFrame":"Baseline, Week 71"},{"measure":"Change From Baseline in CSF Biomarker Phosphorylated Tau","description":"Cerebrospinal fluid samples are collected for analysis of concentration of phosphorylated tau. LS Mean was determined by ANCOVA with LOCF and with factors for treatment, baseline biomarker and age at baseline.","timeFrame":"Baseline, Week 71"},{"measure":"Change From Baseline in Brain Amyloid Burden Using Florbetapir Amyloid Positron Emission Tomography (PET) Scan","description":"Amyloid deposition in the brain is one of the defining neuropathologic findings of Alzheimer's disease. Florbetapir exhibits high affinity specific binding to amyloid plaques. The change from baseline was measured as average standard uptake value ratio (SUVr) in prespecified regions of interest (ROI) assessed by florbetapir amyloid PET imaging in a subset of participants. The Centiloid scale standardizes quantitative brain amyloid PET results to allow cross-tracer and cross-methodology comparisons. The Centiloid scale anchor points are 0 and 100, where 0 represents a high-certainty amyloid negative scan and 100 represents the amount of global amyloid deposition found in a typical AD scans. Florbetapir SUVr was converted to the Centiloid scale using the following conversion: Florbetapir Centiloids = 183 x SUVr - 177. LS Mean was determined by using ANCOVA methodology with terms for treatment, baseline biomarker and age at baseline.","timeFrame":"Baseline, Week 78"},{"measure":"Change From Baseline in Regional Cerebral Blood Flow (rCBF) Using Florbetapir Perfusion Scan","description":"Florbetapir perfusion evaluated the regional cerebral blood flow (rCBF) as a biomarker of brain function and was performed at the same time as the amyloid florbetapir PET. Cerebral perfusion, especially in temporal and parietal areas, is reduced in AD and this pattern of hypoperfusion closely mirrors the hypometabolism pattern observed using FDG PET. Annualized change is derived as change at LOCF divided by (LOCF date - baseline date) multiplied by 365. LS Mean was determined by ANCOVA with LOCF (last observation carried forward) and with factors for treatment, baseline biomarker and age at baseline.","timeFrame":"Baseline, Week 78"},{"measure":"Change From Baseline in Whole Brain Volume","description":"Magnetic resonance imaging (MRI) was used to evaluate the effect of lanabecestat on brain atrophy/whole brain volumes. Annualized change is derived as change at LOCF divided by (LOCF date - baseline date) multiplied by 365. LS Mean was determined by ANCOVA with LOCF and with factors for treatment, baseline volumetric magnetic resonance imaging (vMRI), intracranial volume and age at baseline.","timeFrame":"Baseline, Week 78"},{"measure":"Population Pharmacokinetics (PK): Apparent Oral Clearance of Lanabecestat","description":"The apparent oral clearance of lanabecestat was estimated using a population approach. No covariate effects were assessed as part of this analysis.","timeFrame":"Predose, Week 4, 7, 19, 39, 45 and Week 71 post dose"},{"measure":"Population PK: Central Volume of Distribution of Lanabecestat","description":"The central volume of distribution for lanabecestat was estimated using a population approach. No covariate effects were assessed as part of this analysis.","timeFrame":"Predose, Week 4, 7, 19, 39, 45 and week 71 post dose"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Participant must meet the National Institute on Aging (NIA) and the Alzheimer's Association (AA) (NIA-AA) criteria for probable AD dementia.\n* MMSE score of 20 to 26 inclusive at screening visit.\n* For a diagnosis of mild AD dementia, participant must have a CDR global score of 0.5 or 1, with the memory box score ≥0.5 at screening.\n* Evidence of amyloid pathology.\n* The participant must have a reliable study partner with whom he/she cohabits or has regular contact.\n\nExclusion Criteria:\n\n* Significant and/or current neurological disease affecting the central nervous system, other than AD, that may affect cognition or ability to complete the study, including but not limited to, other dementias, repetitive head trauma, serious infection of the brain, Parkinson's disease, epilepsy, or cervicocranial vascular disease.\n* Participants with any current primary psychiatric diagnosis other than AD if, in the judgment of the investigator, the psychiatric disorder or symptom is likely to confound interpretation of drug effect, affect cognitive assessment, or affect the participant's ability to complete the study. Participants with history of schizophrenia or other chronic psychosis are excluded.\n* Within 1 year before the screening visit or between screening and randomization, any of the following: myocardial infarction; moderate or severe congestive heart failure, New York Heart Association class III or IV; hospitalization for, or symptoms of, unstable angina; syncope due to orthostatic hypotension or unexplained syncope; known significant structural heart disease (such as, significant valvular disease, hypertrophic cardiomyopathy); or hospitalization for arrhythmia.\n* Congenital QT prolongation.\n* Intermittent second- or third-degree atrioventricular (AV) heart block or AV dissociation or history of ventricular tachycardia.\n* A corrected QT (QTcF) interval measurement \\>470 milliseconds (men and women) at screening (as determined at the investigational site).\n* History of malignant cancer within the last 5 years.\n* History of vitiligo and/or current evidence of post-inflammatory hypopigmentation.\n* Calculated creatinine clearance \\<30 milliliters per minute (Cockcroft-Gault formula; Cockcroft and Gault 1976) at screening.\n* Currently enrolled in any other clinical trial involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study.","healthyVolunteers":false,"sex":"ALL","minimumAge":"55 Years","maximumAge":"85 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)","affiliation":"Eli Lilly and Company","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Xenoscience","city":"Phoenix","state":"Arizona","zip":"85004","country":"United States","geoPoint":{"lat":33.44838,"lon":-112.07404}},{"facility":"St Josephs Hospital and Medical Center","city":"Phoenix","state":"Arizona","zip":"85013","country":"United States","geoPoint":{"lat":33.44838,"lon":-112.07404}},{"facility":"Four Peaks Neurology","city":"Scottsdale","state":"Arizona","zip":"85258","country":"United States","geoPoint":{"lat":33.50921,"lon":-111.89903}},{"facility":"Arizona Neurology","city":"Scottsdale","state":"Arizona","zip":"85260","country":"United States","geoPoint":{"lat":33.50921,"lon":-111.89903}},{"facility":"Center for Neurosciences","city":"Tucson","state":"Arizona","zip":"85718","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"NEA Baptist Clinical","city":"Jonesboro","state":"Arkansas","zip":"72401","country":"United States","geoPoint":{"lat":35.8423,"lon":-90.70428}},{"facility":"The Research Center of Southern California","city":"Carlsbad","state":"California","zip":"92011","country":"United States","geoPoint":{"lat":33.15809,"lon":-117.35059}},{"facility":"WCCT Global","city":"Costa Mesa","state":"California","zip":"92626","country":"United States","geoPoint":{"lat":33.64113,"lon":-117.91867}},{"facility":"Neuro-Pain Medical Center","city":"Fresno","state":"California","zip":"93710","country":"United States","geoPoint":{"lat":36.74773,"lon":-119.77237}},{"facility":"Neurology Center of North Orange County","city":"Fullerton","state":"California","zip":"92835","country":"United States","geoPoint":{"lat":33.87029,"lon":-117.92534}},{"facility":"Pacific Neuroscience Medical Group","city":"Oxnard","state":"California","zip":"93030","country":"United States","geoPoint":{"lat":34.1975,"lon":-119.17705}},{"facility":"California Research Foundation","city":"San Diego","state":"California","zip":"92103-6204","country":"United States","geoPoint":{"lat":32.71533,"lon":-117.15726}},{"facility":"Pacific Research Network Inc","city":"San Diego","state":"California","zip":"92103","country":"United States","geoPoint":{"lat":32.71533,"lon":-117.15726}},{"facility":"Sharp Mesa Vista Hospital","city":"San Diego","state":"California","zip":"92123","country":"United States","geoPoint":{"lat":32.71533,"lon":-117.15726}},{"facility":"Syrentis Clinical Research","city":"Santa Ana","state":"California","zip":"92705","country":"United States","geoPoint":{"lat":33.74557,"lon":-117.86783}},{"facility":"Care Access Research","city":"Santa Clarita","state":"California","zip":"91321","country":"United States","geoPoint":{"lat":34.39166,"lon":-118.54259}},{"facility":"California Neuroscience Research","city":"Sherman Oaks","state":"California","zip":"91403","country":"United States","geoPoint":{"lat":34.15112,"lon":-118.44925}},{"facility":"Care Access Research","city":"Valencia","state":"California","zip":"91355","country":"United States","geoPoint":{"lat":34.44361,"lon":-118.60953}},{"facility":"Associated Neurologists, PC - Danbury","city":"Danbury","state":"Connecticut","zip":"06810","country":"United States","geoPoint":{"lat":41.39482,"lon":-73.45401}},{"facility":"Institute for Neurodegenerative Disorders","city":"New Haven","state":"Connecticut","zip":"06510","country":"United States","geoPoint":{"lat":41.30815,"lon":-72.92816}},{"facility":"Yale University School of Medicine","city":"New Haven","state":"Connecticut","zip":"06510","country":"United States","geoPoint":{"lat":41.30815,"lon":-72.92816}},{"facility":"Research Center for Clinical Studies, Inc","city":"Norwalk","state":"Connecticut","zip":"06851","country":"United States","geoPoint":{"lat":41.1176,"lon":-73.4079}},{"facility":"JEM Research Institute","city":"Atlantis","state":"Florida","zip":"33462","country":"United States","geoPoint":{"lat":26.5909,"lon":-80.10088}},{"facility":"Morton Plant Hospital","city":"Clearwater","state":"Florida","zip":"33755","country":"United States","geoPoint":{"lat":27.96585,"lon":-82.8001}},{"facility":"Brain Matters Research","city":"Delray Beach","state":"Florida","zip":"33445","country":"United States","geoPoint":{"lat":26.46146,"lon":-80.07282}},{"facility":"Cohen Medical Associates P.A.","city":"Delray Beach","state":"Florida","zip":"33446","country":"United States","geoPoint":{"lat":26.46146,"lon":-80.07282}},{"facility":"Neuropsychiatric Research Center of Southwest Florida","city":"Fort Myers","state":"Florida","zip":"33912","country":"United States","geoPoint":{"lat":26.62168,"lon":-81.84059}},{"facility":"Indago Research & Health Center, Inc.","city":"Hialeah","state":"Florida","zip":"33012","country":"United States","geoPoint":{"lat":25.8576,"lon":-80.27811}},{"facility":"Infinity Clinical Research, LLC","city":"Hollywood","state":"Florida","zip":"33021","country":"United States","geoPoint":{"lat":26.0112,"lon":-80.14949}},{"facility":"Jacksonville Center for Clinical Research","city":"Jacksonville","state":"Florida","zip":"32216","country":"United States","geoPoint":{"lat":30.33218,"lon":-81.65565}},{"facility":"Mayo Clinic-Jacksonville","city":"Jacksonville","state":"Florida","zip":"32224","country":"United States","geoPoint":{"lat":30.33218,"lon":-81.65565}},{"facility":"Gregory A. Kirk MD LLC","city":"Merritt Island","state":"Florida","zip":"32955","country":"United States","geoPoint":{"lat":28.53917,"lon":-80.672}},{"facility":"University of Miami","city":"Miami","state":"Florida","zip":"33136","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Allied Biomedical Research Institute, Inc.","city":"Miami","state":"Florida","zip":"33155","country":"United States","geoPoint":{"lat":25.77427,"lon":-80.19366}},{"facility":"Compass Research","city":"Orlando","state":"Florida","zip":"32806","country":"United States","geoPoint":{"lat":28.53834,"lon":-81.37924}},{"facility":"Quantum Laboratories","city":"Pompano Beach","state":"Florida","zip":"33064","country":"United States","geoPoint":{"lat":26.23786,"lon":-80.12477}},{"facility":"Charlotte Neurological Services","city":"Port Charlotte","state":"Florida","zip":"33980","country":"United States","geoPoint":{"lat":26.97617,"lon":-82.09064}},{"facility":"Intercoastal Medical Group","city":"Sarasota","state":"Florida","zip":"34239","country":"United States","geoPoint":{"lat":27.33643,"lon":-82.53065}},{"facility":"Axiom Research","city":"Tampa","state":"Florida","zip":"33609","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}},{"facility":"University of South Florida","city":"Tampa","state":"Florida","zip":"33616","country":"United States","geoPoint":{"lat":27.94752,"lon":-82.45843}},{"facility":"Emory University","city":"Atlanta","state":"Georgia","zip":"30329","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Atlanta Center of Medical Research","city":"Atlanta","state":"Georgia","zip":"30331","country":"United States","geoPoint":{"lat":33.749,"lon":-84.38798}},{"facility":"Georgia Regents University","city":"Augusta","state":"Georgia","zip":"30912","country":"United States","geoPoint":{"lat":33.47097,"lon":-81.97484}},{"facility":"Medical Research Health and Education Foundation, Inc","city":"Columbus","state":"Georgia","zip":"31909","country":"United States","geoPoint":{"lat":32.46098,"lon":-84.98771}},{"facility":"Hawaii Medical Center","city":"Honolulu","state":"Hawaii","zip":"96817","country":"United States","geoPoint":{"lat":21.30694,"lon":-157.85833}},{"facility":"Advanced Clinical Research LLC","city":"Meridian","state":"Idaho","zip":"83642","country":"United States","geoPoint":{"lat":43.61211,"lon":-116.39151}},{"facility":"American Health Network","city":"Avon","state":"Indiana","zip":"46123","country":"United States","geoPoint":{"lat":39.76282,"lon":-86.39972}},{"facility":"Josephson Wallack Munshower Neurology","city":"Indianapolis","state":"Indiana","zip":"46256","country":"United States","geoPoint":{"lat":39.76838,"lon":-86.15804}},{"facility":"American Health Network","city":"Muncie","state":"Indiana","zip":"47304","country":"United States","geoPoint":{"lat":40.19338,"lon":-85.38636}},{"facility":"University of Kansas Hospital","city":"Fairway","state":"Kansas","zip":"66160","country":"United States","geoPoint":{"lat":39.02223,"lon":-94.6319}},{"facility":"Cotton O'Neil Clinic","city":"Topeka","state":"Kansas","zip":"66606","country":"United States","geoPoint":{"lat":39.04833,"lon":-95.67804}},{"facility":"Via Christi Research, Inc.","city":"Wichita","state":"Kansas","zip":"67214","country":"United States","geoPoint":{"lat":37.69224,"lon":-97.33754}},{"facility":"Baptist Health Medical Group","city":"Lexington","state":"Kentucky","zip":"40503","country":"United States","geoPoint":{"lat":37.98869,"lon":-84.47772}},{"facility":"Associates in Neurology, PSC","city":"Lexington","state":"Kentucky","zip":"40513","country":"United States","geoPoint":{"lat":37.98869,"lon":-84.47772}},{"facility":"Eastern Maine Medical Center","city":"Bangor","state":"Maine","zip":"04401","country":"United States","geoPoint":{"lat":44.80118,"lon":-68.77781}},{"facility":"Maine Neurology","city":"Scarborough","state":"Maine","zip":"04074","country":"United States","geoPoint":{"lat":43.57814,"lon":-70.32172}},{"facility":"Boston University Medical Center","city":"Boston","state":"Massachusetts","zip":"02118","country":"United States","geoPoint":{"lat":42.35843,"lon":-71.05977}},{"facility":"Donald S Marks","city":"Plymouth","state":"Massachusetts","zip":"02360-4843","country":"United States","geoPoint":{"lat":41.95844,"lon":-70.66726}},{"facility":"Alzheimers Disease Center","city":"Winchester","state":"Massachusetts","zip":"01890","country":"United States","geoPoint":{"lat":42.45232,"lon":-71.137}},{"facility":"Michigan State University","city":"East Lansing","state":"Michigan","zip":"48824","country":"United States","geoPoint":{"lat":42.73698,"lon":-84.48387}},{"facility":"Hattiesburg Clinic","city":"Hattiesburg","state":"Mississippi","zip":"39401","country":"United States","geoPoint":{"lat":31.32712,"lon":-89.29034}},{"facility":"Clinical Research Professionals","city":"Saint Louis","state":"Missouri","zip":"63141","country":"United States","geoPoint":{"lat":38.62727,"lon":-90.19789}},{"facility":"Las Vegas Medical Research","city":"Las Vegas","state":"Nevada","zip":"89113","country":"United States","geoPoint":{"lat":36.17497,"lon":-115.13722}},{"facility":"Advanced Memory Research Institute of New Jersey","city":"Toms River","state":"New Jersey","zip":"08755","country":"United States","geoPoint":{"lat":39.95373,"lon":-74.19792}},{"facility":"Neurology Specialists of Monmouth County","city":"West Long Branch","state":"New Jersey","zip":"07764","country":"United States","geoPoint":{"lat":40.29039,"lon":-74.01764}},{"facility":"New York University Medical Center","city":"New York","state":"New York","zip":"10016","country":"United States","geoPoint":{"lat":40.71427,"lon":-74.00597}},{"facility":"Behavioral Health Center Research","city":"Charlotte","state":"North Carolina","zip":"28211","country":"United States","geoPoint":{"lat":35.22709,"lon":-80.84313}},{"facility":"Raleigh Neurology Associates","city":"Raleigh","state":"North Carolina","zip":"27607","country":"United States","geoPoint":{"lat":35.7721,"lon":-78.63861}},{"facility":"PMG Research of Winston-Salem, LLC","city":"Winston-Salem","state":"North Carolina","zip":"27103","country":"United States","geoPoint":{"lat":36.09986,"lon":-80.24422}},{"facility":"Wake Forest Baptist Univ CAR","city":"Winston-Salem","state":"North Carolina","zip":"27157","country":"United States","geoPoint":{"lat":36.09986,"lon":-80.24422}},{"facility":"Rapid Medical Research Inc","city":"Cleveland","state":"Ohio","zip":"44122","country":"United States","geoPoint":{"lat":41.4995,"lon":-81.69541}},{"facility":"Ohio State University Medical Center","city":"Columbus","state":"Ohio","zip":"43210","country":"United States","geoPoint":{"lat":39.96118,"lon":-82.99879}},{"facility":"Insight Clinical Trials","city":"Shaker Heights","state":"Ohio","zip":"44122","country":"United States","geoPoint":{"lat":41.47394,"lon":-81.53707}},{"facility":"Lynn Health Science Institute","city":"Oklahoma City","state":"Oklahoma","zip":"73112","country":"United States","geoPoint":{"lat":35.46756,"lon":-97.51643}},{"facility":"Cutting Edge Research Group","city":"Oklahoma City","state":"Oklahoma","zip":"73116","country":"United States","geoPoint":{"lat":35.46756,"lon":-97.51643}},{"facility":"The Corvallis Clinic P.C.","city":"Corvallis","state":"Oregon","zip":"97330","country":"United States","geoPoint":{"lat":44.56457,"lon":-123.26204}},{"facility":"Summit Research Network Inc","city":"Portland","state":"Oregon","zip":"97210","country":"United States","geoPoint":{"lat":45.52345,"lon":-122.67621}},{"facility":"Clinical Trial Center, LLC, Psychiatry","city":"Jenkintown","state":"Pennsylvania","zip":"19046","country":"United States","geoPoint":{"lat":40.09594,"lon":-75.12517}},{"facility":"Pearl Clinical Research Inc.","city":"Norristown","state":"Pennsylvania","zip":"19401","country":"United States","geoPoint":{"lat":40.1215,"lon":-75.3399}},{"facility":"Rhode Island Mood & Memory Research Institute","city":"East Providence","state":"Rhode Island","zip":"02914","country":"United States","geoPoint":{"lat":41.81371,"lon":-71.37005}},{"facility":"Rhode Island Hospital","city":"Providence","state":"Rhode Island","zip":"02903","country":"United States","geoPoint":{"lat":41.82399,"lon":-71.41283}},{"facility":"Butler Hospital","city":"Providence","state":"Rhode Island","zip":"02906","country":"United States","geoPoint":{"lat":41.82399,"lon":-71.41283}},{"facility":"Medical University of South Carolina","city":"Charleston","state":"South Carolina","zip":"29425","country":"United States","geoPoint":{"lat":32.77657,"lon":-79.93092}},{"facility":"Radiant Research","city":"Greer","state":"South Carolina","zip":"29650","country":"United States","geoPoint":{"lat":34.93873,"lon":-82.22706}},{"facility":"Coastal Neurology PA","city":"Port Royal","state":"South Carolina","zip":"29935","country":"United States","geoPoint":{"lat":32.37908,"lon":-80.69261}},{"facility":"Holston Medical Group Clinical Research","city":"Kingsport","state":"Tennessee","zip":"37660","country":"United States","geoPoint":{"lat":36.54843,"lon":-82.56182}},{"facility":"Univ of North Texas Health Science Center","city":"Fort Worth","state":"Texas","zip":"76107","country":"United States","geoPoint":{"lat":32.72541,"lon":-97.32085}},{"facility":"Texas Medical Research Associates, L.L.C.","city":"San Antonio","state":"Texas","zip":"78238","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}},{"facility":"Ericksen Research and Development","city":"Clinton","state":"Utah","zip":"84015","country":"United States","geoPoint":{"lat":41.13967,"lon":-112.0505}},{"facility":"SSM Health Dean Medical Group","city":"Madison","state":"Wisconsin","zip":"53715","country":"United States","geoPoint":{"lat":43.07305,"lon":-89.40123}},{"facility":"University of Calgary","city":"Calgary","state":"Alberta","zip":"T2N 426","country":"Canada","geoPoint":{"lat":51.05011,"lon":-114.08529}},{"facility":"The Medical Arts Health Research Group","city":"West Vancouver","state":"British Columbia","zip":"V7T223","country":"Canada","geoPoint":{"lat":49.36672,"lon":-123.16652}},{"facility":"True North Clinical Research Halifax, LLC","city":"Halifax","state":"Nova Scotia","zip":"B3S1M7","country":"Canada","geoPoint":{"lat":44.64533,"lon":-63.57239}},{"facility":"Bruyere Continuing Care","city":"Ottawa","state":"Ontario","zip":"K1N 5C8","country":"Canada","geoPoint":{"lat":45.41117,"lon":-75.69812}},{"facility":"Kawartha Regional Memory Clinic","city":"Peterborough","state":"Ontario","zip":"K9H2P4","country":"Canada","geoPoint":{"lat":44.30012,"lon":-78.31623}},{"facility":"Toronto Memory Program","city":"Toronto","state":"Ontario","zip":"M3B2S7","country":"Canada","geoPoint":{"lat":43.70011,"lon":-79.4163}},{"facility":"Toronto Sunnybrook Regional Cancer Center","city":"Toronto","state":"Ontario","zip":"M4N 3M5","country":"Canada","geoPoint":{"lat":43.70011,"lon":-79.4163}},{"facility":"CSSS-Institut Universitaire Gériatric de Sherbrooke","city":"Sherbrooke","state":"Qubec","zip":"J1J3H5","country":"Canada","geoPoint":{"lat":45.40008,"lon":-71.89908}},{"facility":"Recherches Neuro-Hippocampe Inc","city":"Gatineau","state":"Quebec","zip":"J8T 8J1","country":"Canada","geoPoint":{"lat":45.47723,"lon":-75.70164}},{"facility":"Q&T Research Sherbrooke Inc","city":"Sherbrooke","state":"Quebec","zip":"J1J 2G2","country":"Canada","geoPoint":{"lat":45.40008,"lon":-71.89908}},{"facility":"Douglas Hospital and Research Centre","city":"Verdun","state":"Quebec","zip":"H4H 1R3","country":"Canada","geoPoint":{"lat":44.0575,"lon":-81.64667}},{"facility":"Xuanwu Hospital-Capital Medical University","city":"Beijing","state":"Beijing","zip":"100053","country":"China","geoPoint":{"lat":39.9075,"lon":116.39723}},{"facility":"Beijing 301 Hospital","city":"Beijing","state":"Beijing","zip":"100853","country":"China","geoPoint":{"lat":39.9075,"lon":116.39723}},{"facility":"Guangzhou First People's Hospital","city":"Guangzhou","state":"Guangdong","zip":"510180","country":"China","geoPoint":{"lat":23.11667,"lon":113.25}},{"facility":"Tangshan Worker Hospital","city":"Tangshan","state":"Hebei","zip":"063000","country":"China","geoPoint":{"lat":39.63333,"lon":118.18333}},{"facility":"Nanjing Drum Tower Hosp Affiliated Hosp of Nanjing Univ Med","city":"Nanjing","state":"Jiangsu","zip":"210008","country":"China","geoPoint":{"lat":32.06167,"lon":118.77778}},{"facility":"Zhongda Hospital-Southeast University","city":"Nanjing","state":"Jiangsu","zip":"210009","country":"China","geoPoint":{"lat":32.06167,"lon":118.77778}},{"facility":"Northern Jiangsu People's Hospital","city":"Yangzhou","state":"Jiangsu","zip":"225001","country":"China","geoPoint":{"lat":32.39722,"lon":119.43583}},{"facility":"Qingdao Municipal Hospital","city":"Qingdao","state":"Shandong","zip":"266071","country":"China","geoPoint":{"lat":36.06488,"lon":120.38042}},{"facility":"Shanghai Tongji Hospital(CCBR site)","city":"Shanghai","state":"Shanghai","zip":"200065","country":"China","geoPoint":{"lat":31.22222,"lon":121.45806}},{"facility":"West China Hospital of Sichuan University","city":"Chengdu","state":"Sichuan","zip":"610041","country":"China","geoPoint":{"lat":30.66667,"lon":104.06667}},{"facility":"The First Affiliated Hospital, Zhejiang University","city":"Hangzhou","state":"Zhejiang","zip":"310003","country":"China","geoPoint":{"lat":30.29365,"lon":120.16142}},{"facility":"The First Affiliated Hospital of Wenzhou Medical College","city":"Wenzhou","state":"Zhejiang","zip":"325035","country":"China","geoPoint":{"lat":27.99942,"lon":120.66682}},{"facility":"Shanghai Huashan Hospital Affil to Fu Dan University","city":"Shanghai","zip":"200040","country":"China","geoPoint":{"lat":31.22222,"lon":121.45806}},{"facility":"Fakultni nemocnice u sv. Anny v Brne","city":"Brno","zip":"65691","country":"Czechia","geoPoint":{"lat":49.19522,"lon":16.60796}},{"facility":"Neurohk s.r.o.","city":"Chocen","zip":"565 01","country":"Czechia","geoPoint":{"lat":50.00161,"lon":16.22303}},{"facility":"Neuropsychiatrie s.r.o","city":"Hradec Kralove","zip":"50009","country":"Czechia","geoPoint":{"lat":50.20923,"lon":15.83277}},{"facility":"Brain-Soultherapy s.r.o","city":"Kladno","zip":"27201","country":"Czechia","geoPoint":{"lat":50.14734,"lon":14.10285}},{"facility":"A-Shine s.r.o.","city":"Plzen","zip":"31200","country":"Czechia","geoPoint":{"lat":49.74747,"lon":13.37759}},{"facility":"Clintrial, s.r.o.","city":"Praha 10","zip":"100 00","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"Neuropsychiatrie s.r.o","city":"Praha 6","zip":"160 00","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"Medical Services Prague s.r.o.","city":"Praha 6","zip":"16000","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"Axon Clinical, s.r.o.","city":"Praha 8","zip":"182 00","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"CCBR-Alborg-DK","city":"Aalborg","zip":"9100","country":"Denmark","geoPoint":{"lat":57.048,"lon":9.9187}},{"facility":"Center For Clinical and Basic Research","city":"Ballerup","zip":"2750","country":"Denmark","geoPoint":{"lat":55.73165,"lon":12.36328}},{"facility":"Rigshospitalet","city":"Copenhagen","zip":"2100 CPH","country":"Denmark","geoPoint":{"lat":55.67594,"lon":12.56553}},{"facility":"Center for Clinical and Basic Research -CCBR","city":"Vejle","zip":"7100","country":"Denmark","geoPoint":{"lat":55.70927,"lon":9.5357}},{"facility":"Institut Claude Pompidou - CMRR","city":"Nice","state":"Alpes Maritimes","zip":"06100","country":"France","geoPoint":{"lat":43.70313,"lon":7.26608}},{"facility":"CHU Rennes/Hopital Sud","city":"Rennes Cedex","state":"Ille Et Vilaine","zip":"35064","country":"France","geoPoint":{"lat":48.11198,"lon":-1.67429}},{"facility":"CHU Saint Etienne - Hopital Nord","city":"Saint Priest en Jarez","state":"Loire","zip":"42270","country":"France","geoPoint":{"lat":45.47501,"lon":4.37614}},{"facility":"Chu De Nancy Hop D'Adultes De Brabois","city":"Vandœuvre-lès-Nancy","state":"Meurthe-et-Moselle","zip":"54511","country":"France","geoPoint":{"lat":48.65,"lon":6.18333}},{"facility":"CHU d'Amiens-Picardie Hopital Sud","city":"Amiens Cedex 1","zip":"80054","country":"France","geoPoint":{"lat":49.9,"lon":2.3}},{"facility":"CHU de Caen Hopital Cote de Nacre","city":"Caen Cedex","zip":"14033","country":"France","geoPoint":{"lat":49.18585,"lon":-0.35912}},{"facility":"APHM Hôpital de la Timone","city":"Marseille","zip":"13385","country":"France","geoPoint":{"lat":43.29551,"lon":5.38958}},{"facility":"Hôpital de la Pitié-Salpêtrière","city":"Paris","zip":"75013","country":"France","geoPoint":{"lat":48.85341,"lon":2.3488}},{"facility":"CHU Strasbourg Hôpital de Hautepierre","city":"Strasbourg Cedex","zip":"67098","country":"France","geoPoint":{"lat":48.58392,"lon":7.74553}},{"facility":"Chu de Toulouse Hopital de La Grave","city":"Toulouse Cedex","zip":"31059","country":"France","geoPoint":{"lat":43.60426,"lon":1.44367}},{"facility":"Praxis Dr. Erich Scholz","city":"Böblingen","state":"Baden-Württemberg","zip":"71034","country":"Germany","geoPoint":{"lat":48.68212,"lon":9.01171}},{"facility":"ISPG - Institut für Studien zur psychischen Gesundheit","city":"Mannheim","state":"Baden-Württemberg","zip":"68165","country":"Germany","geoPoint":{"lat":49.4891,"lon":8.46694}},{"facility":"Praxis für Neurologie und Psychiatrie Dr. med. Roth","city":"Ostfildern","state":"Baden-Württemberg","zip":"73760","country":"Germany","geoPoint":{"lat":48.72704,"lon":9.24954}},{"facility":"Neurozentrum Sophienstraße","city":"Stuttgart","state":"Baden-Württemberg","zip":"70178","country":"Germany","geoPoint":{"lat":48.78232,"lon":9.17702}},{"facility":"Klinikum der Universität München","city":"München","state":"Bayern","zip":"81377","country":"Germany","geoPoint":{"lat":48.13743,"lon":11.57549}},{"facility":"Klinikum Rechts der Isar der TU München","city":"München","state":"Bayern","zip":"81675","country":"Germany","geoPoint":{"lat":48.13743,"lon":11.57549}},{"facility":"Neuropraxis München Süd","city":"Unterhaching","state":"Bayern","zip":"82008","country":"Germany","geoPoint":{"lat":48.06598,"lon":11.61564}},{"facility":"Diakoniekrankenhaus Henriettenstiftung Hannover","city":"Hannover","state":"Niedersachsen","zip":"30559","country":"Germany","geoPoint":{"lat":52.37052,"lon":9.73322}},{"facility":"MVZ LiO Berlin","city":"Berlin","zip":"12209","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"Policlinico Univ. Agostino Gemelli","city":"Roma","state":"Lazio","zip":"00168","country":"Italy","geoPoint":{"lat":41.89193,"lon":12.51133}},{"facility":"Spedali Civili - Universita degli Studi","city":"Brescia","zip":"25123","country":"Italy","geoPoint":{"lat":45.53558,"lon":10.21472}},{"facility":"Azienda Ospedaliera Universitaria Careggi","city":"Firenze","zip":"50134","country":"Italy","geoPoint":{"lat":43.77925,"lon":11.24626}},{"facility":"Ente Ospedaliero Ospedali Galliera","city":"Genova","zip":"16128","country":"Italy","geoPoint":{"lat":44.40478,"lon":8.94438}},{"facility":"IRCCS Azienda Ospedaliera Universitaria San Martino","city":"Genova","zip":"16132","country":"Italy","geoPoint":{"lat":44.40478,"lon":8.94438}},{"facility":"SDN - Istituto di Ricerca Diagnostica e Nucleare","city":"Napoli","zip":"80143","country":"Italy","geoPoint":{"lat":40.85216,"lon":14.26811}},{"facility":"Azienda Ospedaliera - Universitaria Pisana","city":"Pisa","zip":"56126","country":"Italy","geoPoint":{"lat":43.70853,"lon":10.4036}},{"facility":"IRCCS Santa Lucia","city":"Roma","zip":"00179","country":"Italy","geoPoint":{"lat":41.89193,"lon":12.51133}},{"facility":"Universita La Sapienza","city":"Roma","zip":"00185","country":"Italy","geoPoint":{"lat":41.89193,"lon":12.51133}},{"facility":"Azienda Ospedaliera Citta della Salute della Scienza Torino","city":"Torino","zip":"10126","country":"Italy","geoPoint":{"lat":45.07049,"lon":7.68682}},{"facility":"Shinwakai Yachiyo Hospital","city":"Anjo-shi","state":"Aichi-Ken","zip":"446-8510","country":"Japan","geoPoint":{"lat":34.95828,"lon":137.08054}},{"facility":"Nagoya Ekisaikai Hospital","city":"Nagoya-shi","state":"Aichi-Ken","zip":"454-8502","country":"Japan","geoPoint":{"lat":35.18147,"lon":136.90641}},{"facility":"Kojunkai Daido Hospital","city":"Nagoya-Shi","state":"Aichi-Ken","zip":"457-8511","country":"Japan","geoPoint":{"lat":35.18147,"lon":136.90641}},{"facility":"Inage Neurology and Memory Clinic","city":"Chiba-shi","state":"Chiba-Ken","zip":"263-0043","country":"Japan","geoPoint":{"lat":35.6,"lon":140.11667}},{"facility":"Ehime University Hospital","city":"Toon-Shi","state":"Ehime-Ken","zip":"791-0295","country":"Japan","geoPoint":{"lat":33.79427,"lon":132.89011}},{"facility":"Jisenkai Nanko Psychiatric Institute","city":"Shirakawa-shi","state":"Fukushima-Ken","zip":"961-0021","country":"Japan"},{"facility":"Takeda General Hospital","city":"Aizu-Wakamatsu","state":"Fukushima","zip":"965-8585","country":"Japan","geoPoint":{"lat":37.49142,"lon":139.94546}},{"facility":"Koseikai Kusatsu Hospital","city":"Hiroshima-shi","state":"Hiroshima-Ken","zip":"733-0864","country":"Japan","geoPoint":{"lat":34.4,"lon":132.45}},{"facility":"NHO Hiroshima-Nishi Medical Center","city":"Otaki-Shi","state":"Hiroshima-Ken","zip":"739-0696","country":"Japan"},{"facility":"Yokohama Hospital","city":"Yokohama","state":"Kanagawa","zip":"221-0801","country":"Japan","geoPoint":{"lat":35.43333,"lon":139.65}},{"facility":"Koseikai Takeda Hospital","city":"Kyoto-Shi","state":"Kyoto-Fu","zip":"600-8558","country":"Japan","geoPoint":{"lat":35.02107,"lon":135.75385}},{"facility":"Uji Takeda Hospital","city":"Uji-Shi","state":"Kyoto-Fu","zip":"611-0021","country":"Japan","geoPoint":{"lat":34.89044,"lon":135.80325}},{"facility":"JADECOM Nara City Hospital","city":"Nara-Shi","state":"Nara-Ken","zip":"630-8305","country":"Japan","geoPoint":{"lat":34.68505,"lon":135.80485}},{"facility":"Nara Medical University Hospital","city":"Kashihara","state":"Nara","zip":"634-8522","country":"Japan","geoPoint":{"lat":34.50896,"lon":135.7929}},{"facility":"Oita University Hospital","city":"Yufu-shi","state":"Oita-Ken","zip":"879-5593","country":"Japan","geoPoint":{"lat":33.1956,"lon":131.37829}},{"facility":"Katayama Medical Clinic","city":"Kurashiki-shi","state":"Okayama-Ken","zip":"710-0813","country":"Japan","geoPoint":{"lat":34.58333,"lon":133.76667}},{"facility":"Himuro Neurology Clinic","city":"Osaka-Shi","state":"Osaka-Fu","zip":"534-0021","country":"Japan","geoPoint":{"lat":34.69374,"lon":135.50218}},{"facility":"Kotobukikai Tominaga Clinic","city":"Osaka-shi","state":"Osaka-Fu","zip":"556-0015","country":"Japan","geoPoint":{"lat":34.69374,"lon":135.50218}},{"facility":"Kousaiin Hospital","city":"Suita-shi","state":"Osaka-Fu","zip":"565-0874","country":"Japan","geoPoint":{"lat":34.76143,"lon":135.51567}},{"facility":"NHO Hizen Psychiatric Center","city":"Kanzaki-gun","state":"Saga-Ken","zip":"842-0192","country":"Japan"},{"facility":"Shimizu Hospital","city":"Shizuoka-shi","state":"Shizuoka","zip":"424-8636","country":"Japan","geoPoint":{"lat":34.98333,"lon":138.38333}},{"facility":"Keikokai P-One Clinic","city":"Hachioji-shi","state":"Tokyo-To","zip":"192-0071","country":"Japan","geoPoint":{"lat":35.65583,"lon":139.32389}},{"facility":"Memory Clinic Ochanomizu","city":"Bunkyo-ku","state":"Tokyo","zip":"113-0034","country":"Japan","geoPoint":{"lat":35.37517,"lon":139.92991}},{"facility":"Juntendo University Hospital","city":"Bunkyo-ku","state":"Tokyo","zip":"113-8431","country":"Japan","geoPoint":{"lat":35.37517,"lon":139.92991}},{"facility":"Musashino Red Cross Hospital","city":"Musashino","state":"Tokyo","zip":"180-8610","country":"Japan","geoPoint":{"lat":35.70611,"lon":139.55944}},{"facility":"JOHAS Sanin Rosai Hospital","city":"Yonago-shi","state":"Tottori-Ken","zip":"683-8605","country":"Japan","geoPoint":{"lat":35.43333,"lon":133.33333}},{"facility":"Aomori Prefectural Centeral Hospital","city":"Aomori","zip":"030-8553","country":"Japan","geoPoint":{"lat":40.81667,"lon":140.73333}},{"facility":"Ikeuchi Psycho Induced Internal Clinic","city":"Kobe-shi","zip":"655-0037","country":"Japan","geoPoint":{"lat":34.6913,"lon":135.183}},{"facility":"Yuge Hospital","city":"Kumamoto","zip":"861-8002","country":"Japan","geoPoint":{"lat":32.80589,"lon":130.69182}},{"facility":"NHO Niigata Hospital","city":"Niigata","zip":"945-8585","country":"Japan","geoPoint":{"lat":37.88637,"lon":139.00589}},{"facility":"NHO Hokkaido Medical Center","city":"Sapporo-shi","zip":"063-0005","country":"Japan","geoPoint":{"lat":43.06667,"lon":141.35}},{"facility":"Dong-A University Medical Center","city":"Busan","state":"Busan Gwang'yeogsi","zip":"49201","country":"Korea, Republic of","geoPoint":{"lat":35.10278,"lon":129.04028}},{"facility":"The Catholic University of Korea-Bucheon St. Mary's Hospital","city":"Bucheon-si","state":"Gyeonggi-do","zip":"14647","country":"Korea, Republic of","geoPoint":{"lat":37.49889,"lon":126.78306}},{"facility":"Myongji Hospital","city":"Goyang-si","state":"Gyeonggi-do","zip":"13620","country":"Korea, Republic of","geoPoint":{"lat":37.65639,"lon":126.835}},{"facility":"Seoul National University Bundang Hospital","city":"Seongnam-si","state":"Gyeonggi-do","zip":"13620","country":"Korea, Republic of","geoPoint":{"lat":37.43861,"lon":127.13778}},{"facility":"Inha University Hospital","city":"Incheon","zip":"22332","country":"Korea, Republic of","geoPoint":{"lat":37.45646,"lon":126.70515}},{"facility":"Korea University Anam Hospital","city":"Seoul","zip":"02841","country":"Korea, Republic of","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Seoul National University Hospital","city":"Seoul","zip":"03080","country":"Korea, Republic of","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Hanyang University Medical Center","city":"Seoul","zip":"04763","country":"Korea, Republic of","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Konkuk University Hospital","city":"Seoul","zip":"05030","country":"Korea, Republic of","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Samsung Medical Center","city":"Seoul","zip":"06351","country":"Korea, Republic of","geoPoint":{"lat":37.566,"lon":126.9784}},{"facility":"Hospital Universitario de Saltillo","city":"Saltillo","state":"Coahuila","zip":"25000","country":"Mexico","geoPoint":{"lat":25.42321,"lon":-101.0053}},{"facility":"Mexico Centre for Clinical Research SA de CV","city":"Mexico City","state":"Distrito Federal","zip":"03100","country":"Mexico","geoPoint":{"lat":19.42847,"lon":-99.12766}},{"facility":"Clinical Research Institute S C","city":"Tlalnepantla","state":"Edo De Mex","zip":"54055","country":"Mexico","geoPoint":{"lat":19.54005,"lon":-99.19538}},{"facility":"Hospital Univ. Jose Eleuterio Gonzalez","city":"Monterrey","state":"N.l.","zip":"64460","country":"Mexico","geoPoint":{"lat":25.67507,"lon":-100.31847}},{"facility":"Instituto de Informacion en Salud Mental (INFOSAM)","city":"Monterrey","state":"NL","zip":"64710","country":"Mexico","geoPoint":{"lat":25.67507,"lon":-100.31847}},{"facility":"Accelerium Clinical Research","city":"Monterrey","state":"Nuevo Leon","zip":"64000","country":"Mexico","geoPoint":{"lat":25.67507,"lon":-100.31847}},{"facility":"Centro de Estudios Clinicos y Esp Medicas SC","city":"Monterrey","state":"Nuevo Leon","zip":"64620","country":"Mexico","geoPoint":{"lat":25.67507,"lon":-100.31847}},{"facility":"Avix Investigación Clínica, S.C","city":"Monterrey","state":"Nuevo León","zip":"64710","country":"Mexico","geoPoint":{"lat":25.67507,"lon":-100.31847}},{"facility":"Emotional Brain B.V.","city":"Almere","zip":"1311 RL","country":"Netherlands","geoPoint":{"lat":52.37535,"lon":5.25295}},{"facility":"Brain Research Center","city":"Amsterdam","zip":"1081 GM","country":"Netherlands","geoPoint":{"lat":52.37403,"lon":4.88969}},{"facility":"Amphia Ziekenhuis","city":"Breda","zip":"4818 CK","country":"Netherlands","geoPoint":{"lat":51.58656,"lon":4.77596}},{"facility":"EB Utrecht","city":"Utrecht","zip":"3511 NH","country":"Netherlands","geoPoint":{"lat":52.09083,"lon":5.12222}},{"facility":"Isala Klinieken","city":"Zwolle","zip":"8025 AB","country":"Netherlands","geoPoint":{"lat":52.5125,"lon":6.09444}},{"facility":"NZOZ Wroclawskie Centrum Alzheimerowskie","city":"Wroclaw","state":"Dolnoslaskie","zip":"53 139","country":"Poland","geoPoint":{"lat":51.1,"lon":17.03333}},{"facility":"Podlaskie Centrum Psychogeriatrii","city":"Białystok","state":"Podlaskie","zip":"15-732","country":"Poland","geoPoint":{"lat":53.13333,"lon":23.16433}},{"facility":"Uniwersyteckie Centrum Kliniczne","city":"Gdansk","state":"Pomorskie","zip":"80-952","country":"Poland","geoPoint":{"lat":54.35205,"lon":18.64637}},{"facility":"NZOZ Mach-Med","city":"Chorzow","zip":"41-506","country":"Poland","geoPoint":{"lat":50.30582,"lon":18.9742}},{"facility":"Klinika Neurologii Neuro-Care","city":"Katowice","zip":"40749","country":"Poland","geoPoint":{"lat":50.25841,"lon":19.02754}},{"facility":"Globe Badania Kliniczne SP Z O.O.","city":"Klodzko","zip":"57-300","country":"Poland","geoPoint":{"lat":50.43488,"lon":16.66145}},{"facility":"Prywatny Gabinet Lekarski U.Chyrchel","city":"Lublin","zip":"20-582","country":"Poland","geoPoint":{"lat":51.25,"lon":22.56667}},{"facility":"Centrum Medyczne Medyk","city":"Rzeszow","zip":"35-055","country":"Poland","geoPoint":{"lat":50.04132,"lon":21.99901}},{"facility":"Euromedis Sp. z o.o.","city":"Szczecin","zip":"70-111","country":"Poland","geoPoint":{"lat":53.42894,"lon":14.55302}},{"facility":"Clinsante Centrum Medyczne","city":"Torun","zip":"87-100","country":"Poland","geoPoint":{"lat":53.01375,"lon":18.59814}},{"facility":"Centrum Medyczne","city":"Warszawa","zip":"01-697","country":"Poland","geoPoint":{"lat":52.22977,"lon":21.01178}},{"facility":"Specjalistyczny Osrodek Medycyny Wieku Dojrzalego SOMED","city":"Warszawa","zip":"01-737","country":"Poland","geoPoint":{"lat":52.22977,"lon":21.01178}},{"facility":"Hospital Fernando Fonseca","city":"Amadora","zip":"2700-351","country":"Portugal","geoPoint":{"lat":38.75382,"lon":-9.23083}},{"facility":"Hospital de Braga","city":"Braga","zip":"4710-243","country":"Portugal","geoPoint":{"lat":41.55032,"lon":-8.42005}},{"facility":"Hospitals da Universidade de Coimbra","city":"Coimbra","zip":"3000-075","country":"Portugal","geoPoint":{"lat":40.20564,"lon":-8.41955}},{"facility":"SAIH Republ. Clinical Hospital of the MoH of Republ. Tatarst","city":"Kazan","zip":"420064","country":"Russian Federation","geoPoint":{"lat":55.78874,"lon":49.12214}},{"facility":"SIH Kemerovo Regional Clinical Hosptial","city":"Kemerovo","zip":"650066","country":"Russian Federation","geoPoint":{"lat":55.33333,"lon":86.08333}},{"facility":"FSBIH Siberian Clinical Center of FMBA","city":"Krasnoyarsk","zip":"660049","country":"Russian Federation","geoPoint":{"lat":56.01839,"lon":92.86717}},{"facility":"LLC City Neurological Centre Sibneuromed","city":"Novosibirsk","zip":"630091","country":"Russian Federation","geoPoint":{"lat":55.0415,"lon":82.9346}},{"facility":"Novosibirsk State Medical University","city":"Novosibirsk","zip":"630091","country":"Russian Federation","geoPoint":{"lat":55.0415,"lon":82.9346}},{"facility":"Ultramed","city":"Omsk","zip":"644024","country":"Russian Federation","geoPoint":{"lat":54.99244,"lon":73.36859}},{"facility":"LLC Treatment and Rehabilitation","city":"Rostov-on-Don","zip":"344010","country":"Russian Federation","geoPoint":{"lat":47.23135,"lon":39.72328}},{"facility":"RSBIH Smolensk Regional Clinical Hospital","city":"Smolensk","zip":"214018","country":"Russian Federation","geoPoint":{"lat":54.7818,"lon":32.0401}},{"facility":"Bekhterev Psyconeurological Institute","city":"St. Petersburg","zip":"192019","country":"Russian Federation","geoPoint":{"lat":59.93863,"lon":30.31413}},{"facility":"Central Medical Sanitary Hospital #122","city":"St. Petersburg","zip":"194291","country":"Russian Federation","geoPoint":{"lat":59.93863,"lon":30.31413}},{"facility":"Regional State Institution of Healthcare Tomsk Clinica Psych","city":"Tomsk","zip":"634014","country":"Russian Federation","geoPoint":{"lat":56.49771,"lon":84.97437}},{"facility":"Hospital Cardiovascular San Vicente","city":"San Vicente del Raspeig","state":"Alicante","zip":"03690","country":"Spain","geoPoint":{"lat":38.3964,"lon":-0.5255}},{"facility":"Hospital General de Catalunya","city":"Sant Cugat del Valles","state":"Barcelona","zip":"08190","country":"Spain","geoPoint":{"lat":41.47063,"lon":2.08611}},{"facility":"Hospital Mutua de Terrassa","city":"Terrassa","state":"Barcelona","zip":"08221","country":"Spain","geoPoint":{"lat":41.56667,"lon":2.01667}},{"facility":"Hospital Virgen Del Puerto","city":"Plasencia","state":"Caceres","zip":"10600","country":"Spain","geoPoint":{"lat":40.03116,"lon":-6.08845}},{"facility":"Policlinica Guipuzcoa","city":"Donostia","state":"Guipuzcoa","zip":"20009","country":"Spain","geoPoint":{"lat":43.31283,"lon":-1.97499}},{"facility":"Hospital Ntra Sra Perpetuo Socorro","city":"Albacete","zip":"02006","country":"Spain","geoPoint":{"lat":38.99424,"lon":-1.85643}},{"facility":"Hospital del Mar","city":"Barcelona","zip":"08003","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Fundacion ACE-Institut Catala de Neurociences Aplicades","city":"Barcelona","zip":"08028","country":"Spain","geoPoint":{"lat":41.38879,"lon":2.15899}},{"facility":"Hospital Universitario La Fe de Valencia","city":"Valencia","zip":"46026","country":"Spain","geoPoint":{"lat":39.46975,"lon":-0.37739}},{"facility":"Cardinal Tien Hospital","city":"Sindian City","state":"Taipei County","zip":"23148","country":"Taiwan","geoPoint":{"lat":24.94062,"lon":121.53111}},{"facility":"National Taiwan University Hospital","city":"Douliu","state":"Yunlin County","zip":"640","country":"Taiwan","geoPoint":{"lat":23.70944,"lon":120.54333}},{"facility":"Changhua Christian Hospital","city":"Changhua","zip":"500","country":"Taiwan","geoPoint":{"lat":24.07327,"lon":120.56276}},{"facility":"Kaohsiung Medical University Chung-Ho Memorial Hospital","city":"Kaohsiung","zip":"807","country":"Taiwan","geoPoint":{"lat":22.61626,"lon":120.31333}},{"facility":"Chang Gung Memorial Hospital - Kaohsiung","city":"Kaohsiung","zip":"83301","country":"Taiwan","geoPoint":{"lat":22.61626,"lon":120.31333}},{"facility":"Taipei Medical University- Shuang Ho Hospital","city":"New Taipei","zip":"23561","country":"Taiwan","geoPoint":{"lat":25.01111,"lon":121.44583}},{"facility":"National Cheng Kung University Hospital","city":"Tainan","zip":"704","country":"Taiwan","geoPoint":{"lat":22.99083,"lon":120.21333}},{"facility":"Taipei Veterans General Hospital","city":"Taipei","zip":"11217","country":"Taiwan","geoPoint":{"lat":25.04776,"lon":121.53185}},{"facility":"Chang Gung Memorial Hospital - Linkou","city":"Taoyuan City","zip":"33305","country":"Taiwan","geoPoint":{"lat":24.95233,"lon":121.20193}},{"facility":"Royal Devon and Exeter Hospital","city":"Exeter","state":"Devon","zip":"EX2 5DW","country":"United Kingdom","geoPoint":{"lat":50.7236,"lon":-3.52751}},{"facility":"Re-Cognition Health Ltd","city":"Plymouth","state":"Devon","zip":"PL6 8BT","country":"United Kingdom","geoPoint":{"lat":50.37153,"lon":-4.14305}},{"facility":"Charlton Lane Hospital","city":"Cheltenham","state":"Gloucestershire","zip":"GL53 9DZ","country":"United Kingdom","geoPoint":{"lat":51.90006,"lon":-2.07972}},{"facility":"Re-Cognition Health Ltd","city":"Guildford","state":"Surrey","zip":"GU2 7YD","country":"United Kingdom","geoPoint":{"lat":51.23536,"lon":-0.57427}},{"facility":"Murray Royal Hospital","city":"Perth","state":"Tayside Region","zip":"PH2 7BH","country":"United Kingdom","geoPoint":{"lat":56.39522,"lon":-3.43139}},{"facility":"Victoria Centre","city":"Swindon","state":"Wiltshire","zip":"SN3 6BW","country":"United Kingdom","geoPoint":{"lat":51.55797,"lon":-1.78116}},{"facility":"Glasgow Memory Clinic","city":"Glasgow","zip":"G20 0XA","country":"United Kingdom","geoPoint":{"lat":55.86515,"lon":-4.25763}},{"facility":"Re-Cognition Health Ltd","city":"London","zip":"W1G9JF","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}}]},"referencesModule":{"references":[{"pmid":"31764959","type":"DERIVED","citation":"Wessels AM, Tariot PN, Zimmer JA, Selzler KJ, Bragg SM, Andersen SW, Landry J, Krull JH, Downing AM, Willis BA, Shcherbinin S, Mullen J, Barker P, Schumi J, Shering C, Matthews BR, Stern RA, Vellas B, Cohen S, MacSweeney E, Boada M, Sims JR. Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials. JAMA Neurol. 2020 Feb 1;77(2):199-209. doi: 10.1001/jamaneurol.2019.3988."},{"pmid":"27767991","type":"DERIVED","citation":"Cebers G, Alexander RC, Haeberlein SB, Han D, Goldwater R, Ereshefsky L, Olsson T, Ye N, Rosen L, Russell M, Maltby J, Eketjall S, Kugler AR. AZD3293: Pharmacokinetic and Pharmacodynamic Effects in Healthy Subjects and Patients with Alzheimer's Disease. J Alzheimers Dis. 2017;55(3):1039-1053. doi: 10.3233/JAD-160701."}],"seeAlsoLinks":[{"label":"Click here for more information about this study: A Study of LY3314814 in Participants With Mild Alzheimer's Disease Dementia (DAYBREAK-ALZ)","url":"https://lillytrialguide.com/en/studies/mild-alzheimer's%20disease/AZET#?postal="},{"label":"CSP","url":"https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=16024&amp;attachmentIdentifier=57afcbfd-0b6e-419e-bfa4-31474a88e3b0&amp;fileName=CSP_NCT02783573.pdf&amp;versionIdentifier="},{"label":"SAP","url":"https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=16024&amp;attachmentIdentifier=88ccbed4-c60c-4494-8962-a9b57b36e8de&amp;fileName=SAP_NCT02783573.pdf&amp;versionIdentifier="}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.","infoTypes":["STUDY_PROTOCOL","SAP","CSR"],"timeFrame":"Data are available 6 months after the primary publication and approval of the indication studied in the US and EU, whichever is later. Data will be indefinitely available for requesting.","accessCriteria":"A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.","url":"https://www.clinicalstudydatarequest.com/"}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"In Period 1, per the protocol, placebo-controlled groups (Placebo for 78 weeks then Lanabecestat 20 mg; Placebo for 78 weeks then Lanabecestat 50 mg) were combined to form one placebo group. As study terminated early and very few participants entered into the period 2, the arms in period 2 are combined based on dose exposure for ease of comparison.","recruitmentDetails":"This study consists of Placebo-Controlled Treatment Period (Weeks 0 to 78) and Delayed-Start Period (Weeks 78 to 156).","groups":[{"id":"FG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"FG001","title":"Lanabecestat 20 Milligrams (mg)","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"FG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"periods":[{"title":"Placebo-Controlled Treatment Period","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"562"},{"groupId":"FG001","numSubjects":"590"},{"groupId":"FG002","numSubjects":"570"}]},{"type":"Received at Least 1 Dose of Study Drug","achievements":[{"groupId":"FG000","numSubjects":"558"},{"groupId":"FG001","numSubjects":"588"},{"groupId":"FG002","numSubjects":"568"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"26"},{"groupId":"FG001","numSubjects":"28"},{"groupId":"FG002","numSubjects":"22"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"536"},{"groupId":"FG001","numSubjects":"562"},{"groupId":"FG002","numSubjects":"548"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"13"},{"groupId":"FG001","numSubjects":"17"},{"groupId":"FG002","numSubjects":"13"}]},{"type":"Death","reasons":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"3"}]},{"type":"Lack of Efficacy","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"2"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"1"}]},{"type":"Non-Compliance","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Other-determined by Investigator","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"2"}]},{"type":"Physician Decision","reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"3"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"15"},{"groupId":"FG001","numSubjects":"20"},{"groupId":"FG002","numSubjects":"23"}]},{"type":"Withdrawal due to Caregiver Circumstance","reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"9"}]},{"type":"Sponsor Decision","reasons":[{"groupId":"FG000","numSubjects":"494"},{"groupId":"FG001","numSubjects":"512"},{"groupId":"FG002","numSubjects":"492"}]}]},{"title":"Delayed-Start Period","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","comment":"Participants from placebo group were randomized to Lanabecestat 20 mg and 50 mg.","numSubjects":"0"},{"groupId":"FG001","comment":"Participants completed period 1 may not have entered period 2 due to early termination of the study.","numSubjects":"17"},{"groupId":"FG002","comment":"Participants completed period 1 may not have entered period 2 due to early termination of the study.","numSubjects":"12"}]},{"type":"Received at Least 1 Dose of Study Drug","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"14"},{"groupId":"FG002","numSubjects":"12"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"17"},{"groupId":"FG002","numSubjects":"12"}]}],"dropWithdraws":[{"type":"Sponsor Decision","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"17"},{"groupId":"FG002","numSubjects":"12"}]}]}]},"baselineCharacteristicsModule":{"populationDescription":"All randomized participants who received at least one dose of study drug.","groups":[{"id":"BG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"BG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"BG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."},{"id":"BG003","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"562"},{"groupId":"BG001","value":"590"},{"groupId":"BG002","value":"570"},{"groupId":"BG003","value":"1722"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"72.1","spread":"7.1"},{"groupId":"BG001","value":"72.3","spread":"7.0"},{"groupId":"BG002","value":"72.6","spread":"7.0"},{"groupId":"BG003","value":"72.3","spread":"7.0"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"348"},{"groupId":"BG001","value":"335"},{"groupId":"BG002","value":"340"},{"groupId":"BG003","value":"1023"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"214"},{"groupId":"BG001","value":"255"},{"groupId":"BG002","value":"230"},{"groupId":"BG003","value":"699"}]}]}]},{"title":"Ethnicity (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Hispanic or Latino","measurements":[{"groupId":"BG000","value":"53"},{"groupId":"BG001","value":"45"},{"groupId":"BG002","value":"55"},{"groupId":"BG003","value":"153"}]},{"title":"Not Hispanic or Latino","measurements":[{"groupId":"BG000","value":"416"},{"groupId":"BG001","value":"442"},{"groupId":"BG002","value":"423"},{"groupId":"BG003","value":"1281"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"93"},{"groupId":"BG001","value":"103"},{"groupId":"BG002","value":"92"},{"groupId":"BG003","value":"288"}]}]}]},{"title":"Race (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"18"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"64"},{"groupId":"BG001","value":"76"},{"groupId":"BG002","value":"69"},{"groupId":"BG003","value":"209"}]},{"title":"Native Hawaiian or Other Pacific Islander","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"4"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"18"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"387"},{"groupId":"BG001","value":"398"},{"groupId":"BG002","value":"389"},{"groupId":"BG003","value":"1174"}]},{"title":"More than one race","measurements":[{"groupId":"BG000","value":"72"},{"groupId":"BG001","value":"70"},{"groupId":"BG002","value":"62"},{"groupId":"BG003","value":"204"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"30"},{"groupId":"BG001","value":"33"},{"groupId":"BG002","value":"32"},{"groupId":"BG003","value":"95"}]}]}]},{"title":"Region of Enrollment","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"United States","categories":[{"measurements":[{"groupId":"BG000","value":"196"},{"groupId":"BG001","value":"205"},{"groupId":"BG002","value":"199"},{"groupId":"BG003","value":"600"}]}]},{"title":"Czechia","categories":[{"measurements":[{"groupId":"BG000","value":"42"},{"groupId":"BG001","value":"42"},{"groupId":"BG002","value":"45"},{"groupId":"BG003","value":"129"}]}]},{"title":"Japan","categories":[{"measurements":[{"groupId":"BG000","value":"38"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"38"},{"groupId":"BG003","value":"119"}]}]},{"title":"United Kingdom","categories":[{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"23"},{"groupId":"BG003","value":"68"}]}]},{"title":"Portugal","categories":[{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"8"},{"groupId":"BG003","value":"24"}]}]},{"title":"Russia","categories":[{"measurements":[{"groupId":"BG000","value":"33"},{"groupId":"BG001","value":"36"},{"groupId":"BG002","value":"31"},{"groupId":"BG003","value":"100"}]}]},{"title":"Spain","categories":[{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"25"},{"groupId":"BG002","value":"28"},{"groupId":"BG003","value":"78"}]}]},{"title":"Canada","categories":[{"measurements":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"33"},{"groupId":"BG002","value":"31"},{"groupId":"BG003","value":"96"}]}]},{"title":"South Korea","categories":[{"measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"20"},{"groupId":"BG003","value":"59"}]}]},{"title":"Netherlands","categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"12"},{"groupId":"BG003","value":"30"}]}]},{"title":"China","categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"2"}]}]},{"title":"Taiwan","categories":[{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"24"}]}]},{"title":"Poland","categories":[{"measurements":[{"groupId":"BG000","value":"39"},{"groupId":"BG001","value":"43"},{"groupId":"BG002","value":"40"},{"groupId":"BG003","value":"122"}]}]},{"title":"Denmark","categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"8"},{"groupId":"BG003","value":"23"}]}]},{"title":"Italy","categories":[{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"21"},{"groupId":"BG003","value":"66"}]}]},{"title":"Mexico","categories":[{"measurements":[{"groupId":"BG000","value":"11"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"29"}]}]},{"title":"France","categories":[{"measurements":[{"groupId":"BG000","value":"30"},{"groupId":"BG001","value":"33"},{"groupId":"BG002","value":"30"},{"groupId":"BG003","value":"93"}]}]},{"title":"Germany","categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"17"},{"groupId":"BG003","value":"60"}]}]}]},{"title":"ADAS-Cog13 (13-item Alzheimer's Disease Assessment Scale)","description":"ADAS-Cog13, a 13-item rating scale, measured the severity of cognitive dysfunction in persons with Alzheimer's disease (AD). Scores ranged from 0 to 85, with a higher score indicating worse cognitive functioning.","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Units on a Scale","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"30.4","spread":"7.9"},{"groupId":"BG001","value":"30.6","spread":"8.3"},{"groupId":"BG002","value":"30.6","spread":"8.5"},{"groupId":"BG003","value":"30.5","spread":"8.2"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Alzheimer´s Disease Assessment Scale- Cognitive Subscale (ADAS-Cog13) Score","description":"ADAS-Cog13 (13-item version of ADAS Cog) is a psychometric instrument that evaluates word recall, ability to follow commands, constructional praxis, naming, ideational praxis, orientation, word recognition, memory, comprehension of spoken language, word-finding, and language ability, with a measure of delayed word recall and concentration/ distractibility. The total score of the 13-item scale ranges from 0 to 85, with an increase in score indicating cognitive worsening. Least Squares (LS) mean was determined by mixed-model repeated measures (MMRM) model with factors for treatment, visit, treatment-by-visit interaction, acetylcholinesterase Inhibitor (AChEI) use at baseline, pooled site, and covariates for baseline ADAS-Cog13 total score, age at baseline, and baseline ADAS-Cog13 total score-by-visit interaction.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for ADAS-Cog13 measure.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Units on a scale","timeFrame":"Baseline, Week 78","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"460"},{"groupId":"OG001","value":"471"},{"groupId":"OG002","value":"464"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.42","spread":"1.23"},{"groupId":"OG001","value":"8.93","spread":"1.11"},{"groupId":"OG002","value":"6.20","spread":"1.32"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.129","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"2.51","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.752","ciUpperLimit":"5.776","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"1.64"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.903","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"-0.21","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.725","ciUpperLimit":"3.296","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"1.76"}]},{"type":"SECONDARY","title":"Change From Baseline in Alzheimer´s Disease Cooperative Study Activities of Daily Living Inventory Instrumental Items Score (ADCS-iADL)","description":"The ADCS-ADL is a 23-item inventory developed as a rater-administered questionnaire answered by the participant's caregiver. The ADCS-ADL measures both basic and instrumental activities of daily living by participants. The range for the ADCS-iADL is 0-59 with higher scores reflecting better performance. LS Mean was determined by MMRM model with factors for treatment, visit, treatment-by-visit interaction, AChEI use at baseline, pooled site, and covariates for baseline iADL score, age at baseline, and baseline iADL score-by-visit interaction.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for ADCS-iADL measure.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Units on a scale","timeFrame":"Baseline, Week 78","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"357"},{"groupId":"OG001","value":"369"},{"groupId":"OG002","value":"347"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-3.95","spread":"1.27"},{"groupId":"OG001","value":"-6.91","spread":"1.29"},{"groupId":"OG002","value":"-7.13","spread":"1.40"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.100","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"-2.95","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-6.488","ciUpperLimit":"0.580","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"1.78"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.092","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"-3.18","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-6.876","ciUpperLimit":"0.525","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"1.86"}]},{"type":"SECONDARY","title":"Change From Baseline in Functional Activities Questionnaire (FAQ) Score","description":"FAQ is a 10-item, caregiver-based questionnaire and was administered to the study partner who was asked to rate the participant's ability to perform a variety of activities ranging from writing checks, assembling tax records, shopping, playing games, food preparation, traveling, keeping appointments, traveling out of neighborhood, keeping track of current events and understanding media. FAQ total score was calculated by adding the scores from each of the 10 items. Each activity is rated on a scale from 0 to 3 (Never did and would have difficulty now=1; never did \\[the activity\\] but could do now=0; normal=0; has difficulty but does by self=1; requires assistance=2; Dependent =3). FAQ scale is 0 to 30, with higher scores indicating greater impairment. LS Mean determined by MMRM model with factors for treatment, visit, treatment-by-visit interaction, AChEI use at baseline, pooled site, and covariates for baseline FAQ total score, by-visit interaction and age at baseline.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for FAQ score.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Units on a scale","timeFrame":"Baseline, Week 78","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"358"},{"groupId":"OG001","value":"369"},{"groupId":"OG002","value":"347"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.93","spread":"0.81"},{"groupId":"OG001","value":"5.16","spread":"0.85"},{"groupId":"OG002","value":"3.41","spread":"0.91"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.285","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"1.23","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.045","ciUpperLimit":"3.499","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"1.14"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.661","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"-0.52","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-2.889","ciUpperLimit":"1.843","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"1.19"}]},{"type":"SECONDARY","title":"Change From Baseline on the Integrated Alzheimer's Disease Rating Scale (iADRS) Score","description":"The iADRS is a composite that measures both cognition and function. The iADRS comprises scores form the ADAS- Cog and the ADCS-iADL. The iADRS is calculated as a linear combination of the total scores of the ADAS-Cog13 (score range 0 to 85 with higher scores reflecting worse performance) and the ADCS-iADL (score range from 0-59 with higher scores reflecting better performance). The iADRS score ranges from 0 to 144 with higher scores indicating greater impairment. LS Mean was determined by MMRM with factors for treatment, visit, treatment-by-visit interaction, AChEI use at baseline, pooled site, and covariates for baseline iADRS13 total score, age at baseline, and baseline iADRS13 total score-by-visit interaction.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for iADRS.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Units on a scale","timeFrame":"Baseline, Week 78","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"342"},{"groupId":"OG001","value":"348"},{"groupId":"OG002","value":"333"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-10.46","spread":"1.97"},{"groupId":"OG001","value":"-15.22","spread":"1.90"},{"groupId":"OG002","value":"-12.43","spread":"2.08"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.079","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"-4.77","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-10.103","ciUpperLimit":"0.56","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"2.69"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.486","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"-1.97","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-7.573","ciUpperLimit":"3.62","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"2.82"}]},{"type":"SECONDARY","title":"Change From Baseline in the Clinical Dementia Rating - Sum of Boxes (CDR-SB) Score","description":"The CDR-SB is a rater administered scale and impairment is scored in each of categories: memory, orientation, judgment and problem solving, community affairs, home and hobbies and personal care. Impairment is scored on a scale in which no dementia = 0, questionable dementia = 0.5, mild dementia = 1, moderate dementia = 2 and severe dementia = 3. The 6 individual category ratings, or \"box scores\", were added together to give the CDR-Sum of Boxes which ranges from 0-18, with higher scores indicating greater impairment. LS Mean was determined by MMRM methodology with factors for treatment, visit, treatment-by-visit interaction, AChEI use at baseline, pooled site, and covariates for baseline CDR-SB score, age at baseline, and baseline CDR-SB score-by-visit interaction.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for CDR-SB.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Units on a scale","timeFrame":"Baseline, Week 78","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"369"},{"groupId":"OG001","value":"370"},{"groupId":"OG002","value":"363"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.32","spread":"0.42"},{"groupId":"OG001","value":"2.57","spread":"0.41"},{"groupId":"OG002","value":"2.10","spread":"0.45"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.663","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"0.25","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.890","ciUpperLimit":"1.391","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"0.57"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.717","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"-0.22","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.423","ciUpperLimit":"0.983","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"0.60"}]},{"type":"SECONDARY","title":"Time to Progression as Measured by Loss of Clinical Dementia Rating (CDR) Global Score Stage","description":"The CDR global score is a composite score calculated using the Washington University CDR-assignment algorithm applied to the 6 individual domain box scores (Morris 1993). The memory domain is considered the primary category that drives the CDR global outcome, and all other domains are secondary. The CDR global score ranges from 0 to 3 (0 = no dementia, 0.5 = questionable dementia, 1 = mild dementia, 2 = moderate dementia, 3 = severe dementia).","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for CDR global score.","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"Days","timeFrame":"From Loss of 1 Global Stage through Week 78","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"479"},{"groupId":"OG001","value":"500"},{"groupId":"OG002","value":"466"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"379","lowerLimit":"367","upperLimit":"546"},{"groupId":"OG001","value":"367","lowerLimit":"365","upperLimit":"456"},{"groupId":"OG002","value":"449","lowerLimit":"365","upperLimit":"491"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Neuropsychiatric Inventory (NPI) Score","description":"The NPI is a questionnaire administered to caregivers that quantifies behavioral changes. Each of the 12 behavioral domains the caregiver reports as present are scored for Frequency, scale: 1 (Occasionally) to 4 (Very Frequently), and Severity, scale: 1 (Mild) to 3 (Severe). If the domain is reported by the caregiver as 'Not Affected,' that domain is scored as 0. The individual domain scores are calculated by multiplying the frequency times the severity for each domain. NPI Total Score is calculated by adding the individual domain scores together for all 12 domains, with a scores range from 0 to 144, with higher scores indicating a greater severity of neuropsychiatric disturbance. LS Mean was determined by MMRM methodology with factors for treatment, visit, treatment-by-visit interaction, AChEI use at baseline, pooled site, and covariates for baseline NPI score, age at baseline, and baseline NPI score-by-visit interaction.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for NPI.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Units on a scale","timeFrame":"Baseline, Week 78","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"351"},{"groupId":"OG001","value":"363"},{"groupId":"OG002","value":"342"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.45","spread":"1.70"},{"groupId":"OG001","value":"3.75","spread":"1.84"},{"groupId":"OG002","value":"0.44","spread":"1.45"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.899","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"0.30","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-4.297","ciUpperLimit":"4.889","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"2.34"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.164","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"-3.01","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-7.267","ciUpperLimit":"1.238","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"2.16"}]},{"type":"SECONDARY","title":"Change From Baseline on the Mini-Mental State Examination (MMSE)","description":"The MMSE is an instrument used to assess a participant's global cognitive function. The MMSE assesses orientation to time and place, immediate and delayed recall of words, attention and calculation, language (naming, comprehension and repetition), and spatial ability (copying a figure). The range for MMSE total Score is 0 to 30, with a higher score indicating better cognitive performance. LS Mean was determined by MMRM methodology with factors for treatment, visit, treatment-by-visit interaction, AChEI use at baseline, pooled site, and covariates for baseline MMSE total score, age at baseline, and baseline MMSE total score-by-visit interaction.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for MMSE.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Units on a scale","timeFrame":"Baseline, Week 78","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"476"},{"groupId":"OG001","value":"495"},{"groupId":"OG002","value":"477"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4.16","spread":"0.59"},{"groupId":"OG001","value":"-5.43","spread":"0.58"},{"groupId":"OG002","value":"-4.31","spread":"0.64"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.126","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"-1.26","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-2.891","ciUpperLimit":"0.362","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"0.82"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.862","statisticalMethod":"Mixed Models Analysis","paramType":"LS Mean Difference (Final Values)","paramValue":"-0.15","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.867","ciUpperLimit":"1.566","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"0.86"}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Concentration of Cerebrospinal Fluid (CSF) Biomarker Amyloid Beta (Aβ)1-42","description":"Concentration of the peptide Aβ 1-42 in plasma measured by validated immunoassay. LS Mean was determined by Analysis of covariance (ANCOVA) with last observation carried forward (LOCF), terms for treatment, baseline biomarker and age at baseline.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for Aβ1-42.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Percent change in Aβ1-42","timeFrame":"Baseline, Week 71","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"5"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23.68","spread":"26.76"},{"groupId":"OG001","value":"-13.87","spread":"24.30"},{"groupId":"OG002","value":"-17.04","spread":"23.26"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.343","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"-37.55","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-122.35","ciUpperLimit":"47.26","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"37.49"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.276","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"-40.72","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-120.17","ciUpperLimit":"38.73","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"35.12"}]},{"type":"SECONDARY","title":"Percent Change From Baseline in Concentration of CSF Biomarker Aβ1-40","description":"Concentration of the peptide Aβ 1-40 in plasma measured by immunoassay. LS Mean was determined by ANCOVA with LOCF (last observation carried forward), terms for treatment, baseline biomarker and age at baseline.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for Aβ1-40.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Percent change in Aβ1-40","timeFrame":"Baseline, Week 71","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"5"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.52","spread":"23.08"},{"groupId":"OG001","value":"-37.42","spread":"20.76"},{"groupId":"OG002","value":"-9.63","spread":"20.74"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.079","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"-61.94","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-132.75","ciUpperLimit":"8.87","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"31.30"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.303","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"-34.15","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-104.88","ciUpperLimit":"36.59","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"31.27"}]},{"type":"SECONDARY","title":"Change From Baseline in CSF Biomarker Total Tau","description":"Cerebrospinal fluid samples were collected for analysis of concentration total tau. LS Mean was determined by ANCOVA with LOCF and with factors for treatment, baseline biomarker and age at baseline.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for CSF Total Tau.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Picogram per milliliter (pg/mL)","timeFrame":"Baseline, Week 71","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"5"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.84","spread":"9.75"},{"groupId":"OG001","value":"18.16","spread":"9.77"},{"groupId":"OG002","value":"-11.21","spread":"9.32"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.283","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"16.32","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-16.015","ciUpperLimit":"48.659","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"14.29"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.349","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"-13.05","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-42.929","ciUpperLimit":"16.820","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"13.21"}]},{"type":"SECONDARY","title":"Change From Baseline in CSF Biomarker Phosphorylated Tau","description":"Cerebrospinal fluid samples are collected for analysis of concentration of phosphorylated tau. LS Mean was determined by ANCOVA with LOCF and with factors for treatment, baseline biomarker and age at baseline.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for CSF Phosphorylated Tau.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Picogram per milliliter (pg/mL)","timeFrame":"Baseline, Week 71","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"5"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.22","spread":"1.54"},{"groupId":"OG001","value":"3.81","spread":"1.49"},{"groupId":"OG002","value":"0.08","spread":"1.41"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.494","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"1.59","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.457","ciUpperLimit":"6.640","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"2.23"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.323","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"-2.13","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-6.743","ciUpperLimit":"2.481","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"2.04"}]},{"type":"SECONDARY","title":"Change From Baseline in Brain Amyloid Burden Using Florbetapir Amyloid Positron Emission Tomography (PET) Scan","description":"Amyloid deposition in the brain is one of the defining neuropathologic findings of Alzheimer's disease. Florbetapir exhibits high affinity specific binding to amyloid plaques. The change from baseline was measured as average standard uptake value ratio (SUVr) in prespecified regions of interest (ROI) assessed by florbetapir amyloid PET imaging in a subset of participants. The Centiloid scale standardizes quantitative brain amyloid PET results to allow cross-tracer and cross-methodology comparisons. The Centiloid scale anchor points are 0 and 100, where 0 represents a high-certainty amyloid negative scan and 100 represents the amount of global amyloid deposition found in a typical AD scans. Florbetapir SUVr was converted to the Centiloid scale using the following conversion: Florbetapir Centiloids = 183 x SUVr - 177. LS Mean was determined by using ANCOVA methodology with terms for treatment, baseline biomarker and age at baseline.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for brain amyloid burden.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Units on a scale","timeFrame":"Baseline, Week 78","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"7"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.43","spread":"10.47"},{"groupId":"OG001","value":"-0.21","spread":"7.79"},{"groupId":"OG002","value":"-17.63","spread":"9.69"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.873","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"2.22","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-26.569","ciUpperLimit":"31.017","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"13.76"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.337","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"-15.20","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-47.488","ciUpperLimit":"17.096","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"15.43"}]},{"type":"SECONDARY","title":"Change From Baseline in Regional Cerebral Blood Flow (rCBF) Using Florbetapir Perfusion Scan","description":"Florbetapir perfusion evaluated the regional cerebral blood flow (rCBF) as a biomarker of brain function and was performed at the same time as the amyloid florbetapir PET. Cerebral perfusion, especially in temporal and parietal areas, is reduced in AD and this pattern of hypoperfusion closely mirrors the hypometabolism pattern observed using FDG PET. Annualized change is derived as change at LOCF divided by (LOCF date - baseline date) multiplied by 365. LS Mean was determined by ANCOVA with LOCF (last observation carried forward) and with factors for treatment, baseline biomarker and age at baseline.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for rCBF.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"Standard Uptake Value ratio (SUVr)","timeFrame":"Baseline, Week 78","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"82"},{"groupId":"OG001","value":"65"},{"groupId":"OG002","value":"66"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.03","spread":"0.01"},{"groupId":"OG001","value":"-0.03","spread":"0.01"},{"groupId":"OG002","value":"-0.03","spread":"0.01"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.927","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"0.00","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.015","ciUpperLimit":"0.017","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"0.01"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.930","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"0.00","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.015","ciUpperLimit":"0.017","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"0.01"}]},{"type":"SECONDARY","title":"Change From Baseline in Whole Brain Volume","description":"Magnetic resonance imaging (MRI) was used to evaluate the effect of lanabecestat on brain atrophy/whole brain volumes. Annualized change is derived as change at LOCF divided by (LOCF date - baseline date) multiplied by 365. LS Mean was determined by ANCOVA with LOCF and with factors for treatment, baseline volumetric magnetic resonance imaging (vMRI), intracranial volume and age at baseline.","populationDescription":"All randomized participants who received at least one dose of study drug and have baseline and at least one post-baseline data for Whole Brain Volume.","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","unitOfMeasure":"cm^3 (cubic centimeter)","timeFrame":"Baseline, Week 78","groups":[{"id":"OG000","title":"Placebo","description":"Participants received placebo film-coated oral tablets once daily."},{"id":"OG001","title":"Lanabecestat 20 mg","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily."},{"id":"OG002","title":"Lanabecestat 50 mg","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"221"},{"groupId":"OG001","value":"215"},{"groupId":"OG002","value":"214"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-15.76","spread":"0.75"},{"groupId":"OG001","value":"-17.38","spread":"0.75"},{"groupId":"OG002","value":"-18.84","spread":"0.76"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.127","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"-1.62","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.708","ciUpperLimit":"0.464","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"1.06"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"0.004","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference (Final Values)","paramValue":"-3.08","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-5.172","ciUpperLimit":"-0.991","dispersionType":"STANDARD_ERROR_OF_MEAN","dispersionValue":"1.06"}]},{"type":"SECONDARY","title":"Population Pharmacokinetics (PK): Apparent Oral Clearance of Lanabecestat","description":"The apparent oral clearance of lanabecestat was estimated using a population approach. No covariate effects were assessed as part of this analysis.","populationDescription":"All randomized participants who received at least 1 dose of study drug with evaluable PK data.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"Geometric Coefficient of Variation","unitOfMeasure":"Liter per hour (L/h)","timeFrame":"Predose, Week 4, 7, 19, 39, 45 and Week 71 post dose","groups":[{"id":"OG000","title":"Lanabecestat","description":"Participants received Lanabecestat film-coated tablets orally."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1077"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.4","spread":"38.8"}]}]}]},{"type":"SECONDARY","title":"Population PK: Central Volume of Distribution of Lanabecestat","description":"The central volume of distribution for lanabecestat was estimated using a population approach. No covariate effects were assessed as part of this analysis.","populationDescription":"All randomized participants who received at least 1 dose of study drug with evaluable PK data.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"Geometric Coefficient of Variation","unitOfMeasure":"Liters (L)","timeFrame":"Predose, Week 4, 7, 19, 39, 45 and week 71 post dose","groups":[{"id":"OG000","title":"Lanabecestat","description":"Participants received Lanabecestat film-coated tablets orally."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"1077"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"77.8","spread":"198"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"Up To 156 Weeks","description":"All randomized participants who received at least one dose of study drug. There are gender specific adverse events, only occurring in male or female participants. The number of participants exposed has been adjusted accordingly.","eventGroups":[{"id":"EG000","title":"Placebo-Period 1","description":"Participants received placebo film-coated oral tablets once daily.","deathsNumAffected":5,"deathsNumAtRisk":558,"seriousNumAffected":50,"seriousNumAtRisk":558,"otherNumAffected":48,"otherNumAtRisk":558},{"id":"EG001","title":"Lanabecestat 20 Mg-Period 1","description":"Participants received lanabecestat 20 mg film-coated oral tablets once daily.","deathsNumAffected":2,"deathsNumAtRisk":588,"seriousNumAffected":50,"seriousNumAtRisk":588,"otherNumAffected":69,"otherNumAtRisk":588},{"id":"EG002","title":"Lanabecestat 50 Mg-Period 1","description":"Participants received lanabecestat 50 mg film-coated oral tablets once daily.","deathsNumAffected":3,"deathsNumAtRisk":568,"seriousNumAffected":46,"seriousNumAtRisk":568,"otherNumAffected":76,"otherNumAtRisk":568},{"id":"EG003","title":"Lanabecestat 20 Mg-Period 2","description":"Participants from placebo group were randomized to receive lanabecestat 20 mg film-coated oral tablets once daily.","deathsNumAffected":0,"deathsNumAtRisk":14,"seriousNumAffected":0,"seriousNumAtRisk":14,"otherNumAffected":5,"otherNumAtRisk":14},{"id":"EG004","title":"Lanabecestat 50 Mg-Period 2","description":"Participants from placebo group were randomized to receive lanabecestat 50 mg film-coated oral tablets once daily.","deathsNumAffected":0,"deathsNumAtRisk":12,"seriousNumAffected":1,"seriousNumAtRisk":12,"otherNumAffected":1,"otherNumAtRisk":12}],"seriousEvents":[{"term":"Iron deficiency anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Acute coronary syndrome","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Atrial flutter","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Atrioventricular block complete","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Cardiac arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Cardio-respiratory arrest","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Chronotropic incompetence","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Coronary artery disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Sinus node dysfunction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Stress cardiomyopathy","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Trifascicular block","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Ventricular fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Gastrointestinal arteriovenous malformation","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Vertigo positional","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Colitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Colitis ischaemic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Diverticulum","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Inguinal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Intestinal obstruction","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Peptic ulcer perforation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Rectal prolapse","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Death","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Feeling abnormal","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Non-cardiac chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Sudden cardiac death","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Cholecystitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Anaphylactic reaction","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Bacteraemia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Bronchitis viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Cellulitis orbital","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Epididymitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":211},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":255},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":229},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":5},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7}]},{"term":"Erysipelas","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Liver abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Orchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":211},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":255},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":229},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":5},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Urosepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Animal bite","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Ankle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Brain contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Clavicle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Craniocerebral injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":588},{"groupId":"EG002","numEvents":5,"numAffected":5,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Femoral neck fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Femur fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Fibula fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Forearm fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Heat exhaustion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Hip fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Humerus fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Lumbar vertebral fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Pelvic fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Post procedural complication","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Pubis fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Rib fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Road traffic accident","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Spinal compression fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Spinal fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Subdural haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Tibia fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Upper limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Wrist fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Prostatic specific antigen increased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":211},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":255},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":229},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":5},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Hypoglycaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Hyponatraemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":3,"numAffected":2,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Cervical spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Muscle haemorrhage","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Muscle spasms","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Adenocarcinoma of colon","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Adenocarcinoma pancreas","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Bladder transitional cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Brain neoplasm","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Breast cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Colon cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Colorectal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Invasive ductal breast carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Lung adenocarcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Ovarian cancer recurrent","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":347},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":333},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":339},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":5}]},{"term":"Ovarian cancer stage ii","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":347},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":333},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":339},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":9},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":5}]},{"term":"Pancreatic carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Papillary thyroid cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Prostate cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":211},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":255},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":229},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":5},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7}]},{"term":"Renal oncocytoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Squamous cell carcinoma of the tongue","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Brain injury","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Cerebellar haematoma","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Cerebral infarction","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Cognitive disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Coma","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Dementia Alzheimer's type","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Generalised tonic-clonic seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Haemorrhage intracranial","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Presyncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Seizure","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":558},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":588},{"groupId":"EG002","numEvents":4,"numAffected":3,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Toxic encephalopathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Device malfunction","organSystem":"Product Issues","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Abnormal behaviour","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Acute psychosis","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Adjustment disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Aggression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Confusional state","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Delirium","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Delusion","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Mental status changes","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Paranoia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Psychotic disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":12}]},{"term":"Acute kidney injury","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Stress urinary incontinence","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Chronic obstructive pulmonary disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Hiccups","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Hypoxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Lung disorder","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Pleural effusion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Pneumonia aspiration","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Pneumothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Respiratory arrest","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Deep vein thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Peripheral ischaemia","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Thrombosis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]}],"otherEvents":[{"term":"Glaucoma","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":558},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":588},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":568},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":19,"numAffected":17,"numAtRisk":558},{"groupId":"EG001","numEvents":35,"numAffected":29,"numAtRisk":588},{"groupId":"EG002","numEvents":39,"numAffected":29,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Influenza like illness","organSystem":"General disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":4,"numAffected":4,"numAtRisk":568},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":34,"numAffected":21,"numAtRisk":558},{"groupId":"EG001","numEvents":37,"numAffected":32,"numAtRisk":588},{"groupId":"EG002","numEvents":49,"numAffected":34,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Blood glucose decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Thyroxine decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":588},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":568},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Hyperlipidaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":568},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Confusional state","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":558},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":588},{"groupId":"EG002","numEvents":9,"numAffected":9,"numAtRisk":568},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":14},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":12}]},{"term":"Psychotic disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":558},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":588},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":568},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":14},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":12}]},{"term":"Benign prostatic hyperplasia","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 21.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":211},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":255},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":229},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":5},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":7}]}]},"moreInfoModule":{"limitationsAndCaveats":{"description":"An independent assessment concluded the trial was not likely to meet the primary endpoint upon completion and therefore, trial stopped for futility."},"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"The sponsor shall review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days from the time submitted to the sponsor for review."},"pointOfContact":{"title":"AstraZeneca Information Center","organization":"AstraZeneca","email":"information.center@astrazeneca.com","phone":"1-877-240-9479"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2016-02-05","uploadDate":"2019-05-28T06:30","filename":"Prot_000.pdf","size":1091020},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2018-09-17","uploadDate":"2019-05-28T06:34","filename":"SAP_001.pdf","size":3796621}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2025-07-25","removedCountries":["Belgium","Czech Republic"]},"conditionBrowseModule":{"meshes":[{"id":"D000544","term":"Alzheimer Disease"},{"id":"D003704","term":"Dementia"}],"ancestors":[{"id":"D001927","term":"Brain Diseases"},{"id":"D002493","term":"Central Nervous System Diseases"},{"id":"D009422","term":"Nervous System Diseases"},{"id":"D024801","term":"Tauopathies"},{"id":"D019636","term":"Neurodegenerative Diseases"},{"id":"D019965","term":"Neurocognitive Disorders"},{"id":"D001523","term":"Mental Disorders"}],"browseLeaves":[{"id":"M6904","name":"Dementia","asFound":"Dementia","relevance":"HIGH"},{"id":"M14473","name":"Psychotic Disorders","relevance":"LOW"},{"id":"M4815","name":"Mental Disorders","relevance":"LOW"},{"id":"M4021","name":"Amyloidosis","relevance":"LOW"},{"id":"M5204","name":"Brain Diseases","relevance":"LOW"},{"id":"M6894","name":"Delirium","relevance":"LOW"},{"id":"M3885","name":"Alzheimer Disease","asFound":"Alzheimer's Disease","relevance":"HIGH"},{"id":"M5742","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M21558","name":"Neurodegenerative Diseases","relevance":"LOW"},{"id":"M23002","name":"Tauopathies","relevance":"LOW"},{"id":"M21836","name":"Neurocognitive Disorders","relevance":"LOW"},{"id":"T2192","name":"Familial Alzheimer Disease","asFound":"Alzheimer's Disease","relevance":"HIGH"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC18","name":"Nutritional and Metabolic Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":true}